Phenolic compounds and chemotherapeutic agents differentially regulate P2X receptor subtypes in malignant melanoma
{{output}}
Melanoma is an aggressive malignancy characterized by high metastatic potential and resistance to conventional therapies. Emerging evidence suggests that purinergic P2X receptors, particularly P2X7, play critical roles in regulating tumor cell proliferation, a... ...
